TrinityPoint Wealth’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

TrinityPoint Wealth’s Portfolio GMDA Stock Details GMDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,000	Closed	-$361	–	331
2024 Q1	$361	Hold	10,000	–	–	﹤0.01%	308
2023 Q4	$4.13K	Hold	10,000	–	–	﹤0.01%	297
2023 Q3	$10.3K	Hold	10,000	–	–	﹤0.01%	287
2023 Q2	$19.3K	Sell	10,000 -10,000	-50%	-$17.2K	﹤0.01%	279
2023 Q1	$16.2K	Hold	20,000	–	–	﹤0.01%	271
2022 Q4	$25.8K	Buy	+20,000	New	+$31.6K	0.01%	276

Other funds holding GMDA

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TrinityPoint Wealth's GMDA Position: Q2 2024 in Review

TrinityPoint Wealth sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 10,000 shares — an estimated $361 sold.

TrinityPoint Wealth first reported a position in GMDA in Q4 2022 and held it in 6 quarters. The position peaked at $25.8K in Q4 2022. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

TrinityPoint Wealth reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
TrinityPoint Wealth sold 10,000 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $361.
TrinityPoint Wealth first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2022 and held it in 6 quarters.
TrinityPoint Wealth's Gamida Cell Ltd. Ordinary Shares position peaked at $25.8K in Q4 2022.
2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on TrinityPoint Wealth's 13F filing for Q2 2024, filed 30 Jul 2024.